Improved prognostic significance of cytokine-induced proliferation in vitro in patients with de novo acute myeloid leukemia of intermediate risk: impact of internal tandem duplications in the Flt3 gene

[1]  B. Löwenberg,et al.  Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene , 2000, Leukemia.

[2]  K. Horibe,et al.  Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia. , 1999, Medical and pediatric oncology.

[3]  A. Martens,et al.  Human acute myeloid leukemia cells with internal tandem duplications in the Flt3 gene show reduced proliferative ability in stroma supported long-term cultures , 1999, Leukemia.

[4]  A. Hagenbeek,et al.  Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia? , 1999, Bone Marrow Transplantation.

[5]  T. Naoe,et al.  Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. , 1999, Blood.

[6]  K Wheatley,et al.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.

[7]  A. Órfão,et al.  Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. , 1998, Leukemia & lymphoma.

[8]  M A Boogaerts,et al.  Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  H. Kojima,et al.  Proliferative effects of several hematopoietic growth factors on acute myelogenous leukemia cells and correlation with treatment outcome , 1997, Leukemia.

[10]  T. Naoe,et al.  Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines , 1997, Leukemia.

[11]  M. Taniwaki,et al.  Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia , 1997, Leukemia.

[12]  C. Bloomfield,et al.  Clinical significance of cytogenetics in acute myeloid leukemia. , 1997, Seminars in oncology.

[13]  H. Kaneko,et al.  Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. , 1996, Leukemia.

[14]  F. Galibert,et al.  Genomic structure of the downstream part of the human FLT3 gene: exon/intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III. , 1994, Gene.

[15]  H. Mckenna,et al.  Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. , 1994, Blood.

[16]  H. Zola,et al.  Cytokine receptor expression in leukaemic cells. , 1994, Leukemia research.

[17]  D. Birnbaum,et al.  The expression of FMS, KIT and FLT3 in hematopoietic malignancies. , 1994, Leukemia & lymphoma.

[18]  N. Russell,et al.  Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. , 1993, Blood.

[19]  T. Bird,et al.  Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene. , 1993, Oncogene.

[20]  W. van Putten,et al.  Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. , 1993, The New England journal of medicine.

[21]  S. Cannistra.  Growth regulation of malignant clonogenic cells in acute myeloid leukemia , 1991, Current opinion in oncology.

[22]  D. Birnbaum,et al.  Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. , 1991, Genomics.

[23]  C. Bartram,et al.  Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. , 1991, Blood.

[24]  G. Wagemaker,et al.  Growth regulation of human acute myeloid leukemia: effects of five recombinant hematopoietic factors in a serum-free culture system , 1988 .

[25]  F. Birg,et al.  c-fms expression is a molecular marker of human acute myeloid leukemias. , 1988, Blood.

[26]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[27]  J. Kirkwood,et al.  In vivo drug sensitivity assay of clonogenic human melanoma cells and correlation with treatment outcome. , 1983, Cancer research.